Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
CORE Biomedicine $21M Series ARege Nephro Co $10.6M Series CInvestor activity and startup funding rounds for the selected month.
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
CORE Biomedicine $21M Series ARege Nephro Co $10.6M Series CNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Act Security $40M Series ABeacon Security $13M SeedNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
ZuriQ $25.5M SeedQuantumDiamonds €15M UndisclosedNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Act Security $40M Series ABeacon Security $13M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Abstract $25M UndisclosedLinqAlpha $22M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Abstract $25M UndisclosedApaluma $5.6M SeedNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Seed 1
kausable €12M SeedSightera Biosciences €3M Pre-SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Prosper Medical $16M UndisclosedJusfy ~$15M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Prosper Medical $16M UndisclosedThira $21M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Notabene Undisclosed StrategicVelocity $38M Series ANew companies 2 · Follow-on 0
Stages: Series A 2
Passionfroot $15M Series AEquiLibre Technologies Undisclosed Series ANew companies 2 · Follow-on 0
Stages: Series B 2
Crystalys Therapeutics $130M Series BDraig Therapeutics $65M Series BNew companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Circular Materials €11.8M UndisclosedProxima Fusion €411M GrowthNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Undisclosed 1
ORiS €5M Pre-SeedQuantumDiamonds €15M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Karoo Health $16.2M Series AHandspring $19M Series B“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.